De-escalation of the antithrombotic therapy is independently associated with low risk of total mortality in patients with acute coronary syndrome (ACS) in real practice
Event:
Acute Cardiovascular Care 2019
Topic:
Pharmacotherapy
Session:
Acute Coronary Syndromes: Pharmacotherapy
